Related references
Note: Only part of the references are listed.Stability and CDR Composition Biases Enrich Binder Functionality Landscapes
Benjamin J. Hackel et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
John Wojcik et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
The full amino acid repertoire is superior to serine/tyrosine for selection of high affinity immunoglobulin G binders from the fibronectin scaffold
Benjamin J. Hackel et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Strategies and challenges for the next generation of therapeutic antibodies
Alain Beck et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Engineered protein scaffolds as next-generation antibody therapeutics
Michaela Gebauer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
FN3: a new protein scaffold reaches the clinic
Laird Bloom et al.
DRUG DISCOVERY TODAY (2009)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
Hsiang-I. Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
mRNA display selection of a high-affinity, modification-specific phospho-IκBα-binding fibronectin
C. Anders Olson et al.
ACS CHEMICAL BIOLOGY (2008)
The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer
Sean P. Dineen et al.
BMC CANCER (2008)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
Anne S. De Groot et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Phage Display Derived Therapeutic Antibodies
Holger Thie et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling
Benjamin J. Hackel et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces
Ryan N. Gilbreth et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Lucy J. Holt et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: Molecular convergence with single-domain camelid and shark antibodies
Dasa Lipovsek et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
High-affinity single-domain binding proteins with a binary-code interface
Akiko Koide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain
C. Anders Olson et al.
PROTEIN SCIENCE (2007)
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro
Elena V. Getmanova et al.
CHEMISTRY & BIOLOGY (2006)
High-affinity fragment complementation of a fibronectin type III domain and its application to stability enhancement
S Dutta et al.
PROTEIN SCIENCE (2005)
Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two
MH Parker et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2005)
Engineered proteins as specific binding reagents
HK Binz et al.
CURRENT OPINION IN BIOTECHNOLOGY (2005)
Molecular recognition by a binary code
FA Fellouse et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Applications of ribosome display to antibody drug discovery
MAT Groves et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition
FA Fellouse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antibodies from phage antibody libraries
ARM Bradbury et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
In-vitro protein evolution by ribosome display and mRNA display
D Lipovsek et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain
E Karatan et al.
CHEMISTRY & BIOLOGY (2004)
Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human αvβ3 integrin
J Richards et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Domain antibodies: proteins for therapy
LJ Holt et al.
TRENDS IN BIOTECHNOLOGY (2003)
Exploring the potential of the monobody scaffold: effects of loop elongation on the stability of a fibronectin type III domain
V Batori et al.
PROTEIN ENGINEERING (2002)
Directed evolution of high-affinity antibody mimics using mRNA display
LH Xu et al.
CHEMISTRY & BIOLOGY (2002)
Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor
A Koide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Two proteins with the same structure respond very differently to mutation: The role of plasticity in protein stability
E Cota et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
